Choose Sandoz for Biosimilars

For more than 100 years, Sandoz has advanced solutions to critical health challenges by providing high-quality, more affordable medicines to patients worldwide. As a global leader in generic medicines and the first company to bring a biosilmilar to market, we are proud to celebrate this heritage with the launch of Choose Sandoz.

Over the coming months, we’ll shine a light on the challenges and opportunities to support a more sustainable healthcare system and improve patient access to biologic medicines – through biosimilars. 

Hear from Pierre Bourdage, Global Head of Biopharmaceuticals, as he kicks off the series.¹